The main goals of Ulcerative Colitis (UC) treatment are to both induce and maintain the
clinical and endoscopic remission of disease, reduce the incidence of complications such as …

Anti-tumor necrosis factor (anti-TNF) therapy has been successfully used as first-line
biologic treatment for moderate-to-severe inflammatory bowel disease (IBD), in both “step …

Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …

Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease
(CD), is a chronic and recurrent disease that seriously affects the life quality of patients …

Inflammatory bowel diseases (IBDs) are chronic, immune-mediated disorders that include
Crohn's disease and ulcerative colitis. A pediatric onset of disease occurs in about 10% of …

Inflammatory bowel disease (IBD) is a chronic relapsing disorder of the gastrointestinal tract,
while the present therapeutic efficacy is insufficient. In recent years, numerous studies have …

In recent years, better knowledge of the pathophysiology of inflammatory bowel diseases
(IBD) has led to a relevant expansion of the therapeutic arsenal for these conditions. Janus …

Introduction Although there are well-defined guidelines for the management of mild-to-
moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted …

Background Biologics and small molecules for inflammatory bowel disease (IBD) may
increase infection risk. Herpes zoster causes acute and long‐term symptoms, but …

Inflammatory bowel diseases, comprising ulcerative colitis (UC) and Crohn's disease, are
chronic, immune-mediated and progressive inflammatory disorders affecting the …